Skip to content
healthcare.dev

Mirabegron

NDC 70771-1753, Mirabegron, tablet, extended release, from Zydus Lifesciences Limited.

Product NDC
70771-1753
Status
Listed
Labeler
Zydus Lifesciences Limited
Dosage form
TABLET, EXTENDED RELEASE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA209488
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/70771-1753 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • MIRABEGRON50 mg/1

Pharmacologic classes

Adrenergic beta3-Agonists [MoA]; Cytochrome P450 2D6 Inhibitors [MoA]; Cytochrome P450 3A Inhibitors [MoA]; P-Glycoprotein Inhibitors [MoA]; beta3-Adrenergic Agonist [EPC]

Package NDCNDC-11Package
70771-1753-170771175301100 TABLET, EXTENDED RELEASE in 1 BOTTLE (70771-1753-1)
70771-1753-37077117530330 TABLET, EXTENDED RELEASE in 1 BOTTLE (70771-1753-3)
70771-1753-97077117530990 TABLET, EXTENDED RELEASE in 1 BOTTLE (70771-1753-9)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/461b2b94-205a-4860-9cb4-d30267ada9df

Use it

Look up 70771-1753 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/70771-1753 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 70771-1753. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.